Weighing benefit and risk of using plasma exchange for treatment of refractory demyelination

Researchers from the National Pediatric Hospital in Buenos Aires, Argentina, describe their experience with therapeutic plasma exchange (TPE) for refractory inflammatory central nervous system (CNS) attacks in children over the course of nearly 15 years.